Sort
1,049,261 grants matching “t cell”
DETERMINANTS OF CELL FATE AND DIFFERENTIATION IN THE DEVELOPING LUNG
$2,289,360Wellington V. Cardoso · Boston University Medical Campus · P01 · FY2011 · HL
Preventive Vaccines for HIV
$2,289,324Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
The quantitative biology of CTLA4 splice variants in T1D
$2,289,228Zhibin Chen · University Of Miami School Of Medicine · DP3 · FY2009 · DK
Genetic and Signaling Pathways in Epithelial Thyroid Cancer
$2,289,198Matthew D Ringel · Ohio State University · P01 · FY2016 · CA
Genetics, Pathophysiology, and Treatment of Dominant Autoinflammatory Diseases
$2,289,054Daniel Kastner · National Human Genome Research Institute · ZIA · FY2021 · HG
Flow Cytometry Core
$2,289,001Stephen Perfetto · National Institute Of Allergy And Infectious Diseases · ZIC · FY2024 · AI
Molecular And Immunopathology Of Experimental And Clinical Ocular Diseases
$2,288,939Chi-Chao Chan · National Eye Institute · Z01 · FY2007 · EY
Center for the Development of Phenotype-Based Treatments of Autism Spectrum Disorder
$2,288,766David G Amaral · University Of California At Davis · P50 · FY2018 · HD
Molecular Genomics Sequencing Core Facility
$2,288,755Vivek Mahadevan · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIC · FY2024 · HD
Frontotemporal Dementias: Genotypes and Phenotypes
$2,288,632Virginia M Lee · University Of Pennsylvania · P01 · FY2018 · AG
Hedgehog signaling regulation of postnatal tongue and taste organ morphogenesis
$2,288,537Archana Kumari · Rowan University School/Osteopathic Med · R01 · FY2025 · DC
Vascular Relations of Blood Cells and Proteins
$2,288,517Richard E Waugh · University Of Rochester · P01 · FY2006 · HL
Evolution and Treatment Response of Brain, Breast, and Hematologic Malignancies
$2,288,376Franziska Michor · Dana-Farber Cancer Inst · U54 · FY2018 · CA
Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.
$2,288,273Michael G Agadjanyan · Institute For Molecular Medicine · R01 · FY2025 · AG
Mechanisms controlling distinct growth and functional characteristics of the perinatal and adult thymus
$2,288,223Ellen R Richie · University Of Tx Md Anderson Can Ctr · P01 · FY2024 · AI
Exosomes as mediators of cardiac injury and repair
$2,288,095Raj Kishore · Temple Univ Of The Commonwealth · P01 · FY2020 · HL
SPORE in Prostate Cancer
$2,288,045Northwestern University · P50 · FY2003 · CA
Chemoprevention of Lung Cancer
$2,288,039Marshall W Anderson · University Of Cincinnati · P01 · FY2007 · CA
Targets of antibody responses in vaccinia virus & protection mechanisms
$2,288,019Bjoern Peters · La Jolla Institute For Immunology · N01 · FY2012 · AI
Microphysiological systems to interrogate the Islet-Liver-Adipose Axis in normal physiology and Type-2 Diabetes Mellitus
$2,287,847Andreas Stahl · University Of California Berkeley · UH3 · FY2022 · DK
Molecular approaches to understand vector-host and vector-pathogen interactions
$2,287,790Jesus Valenzuela · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
T Cell Costimulatory Pathways: Functions and Interactions
$2,287,759Arlene H Sharpe · Harvard Medical School · P01 · FY2017 · AI
Adhesion Molecules in Transfusion Biology
$2,287,751Denisa D Wagner · Immune Disease Institute, Inc. · P01 · FY2007 · HL
Mentoring Research Excellence in Aging and Regenerative Medicine
$2,287,704S Michal Jazwinski · Tulane University Of Louisiana · P20 · FY2019 · GM
Anti-NMDA receptor antibodies in adult brain dsyfunction & fetal brain developmen
$2,287,670Betty Diamond · Feinstein Institute For Medical Research · P01 · FY2014 · AI